Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases, Vesiculobullous

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

235 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Active, Not Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

NCT05464381

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations: Sanatorio Mater Dei Buenos Aires, Argentina

EB-Haus Austria; Salzburger Landeskliniken (SALK) Salzburg, Austria

Fundacion Debra Chile Santiago, Chile

Universitaetsklinik fuer Dermatologie und Allergologie Nice, France

View all 16 locations

View Trial Details

Active, Not Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

NCT05838092

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Masonic Cancer Center and Medical Center Minneapolis Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

NCT04400994

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: Department of Medicine Central, Hong Kong

View Trial Details

Active, Not Recruiting

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

NCT05725018

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Stanford University Redwood City, California, United States

University of Massachusetts Medical School Worcester, Massachusetts, United States

View Trial Details

Active, Not Recruiting

A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center

NCT06949241

Conditions: Autoimmune Diseases, Immune System Diseases, Intravenous Immunoglobulin, +6 more
Locations: Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details